Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M240Revenue $M48.3Net Margin (%)-89.2Altman Z-Score-4.4
Enterprise Value $M221EPS $-0.6Operating Margin %-81.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score-0.4Pre-tax Margin (%)-89.2Higher ROA y-yY
Price/Book5.010-y EBITDA Growth Rate %-7.2Quick Ratio1.0Cash flow > EarningsY
Price/Sales5.15-y EBITDA Growth Rate %-10.7Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-31.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-65.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.6ROIC % (ttm)-159.5Gross Margin Increase y-yN

Gurus Latest Trades with BCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRXJoel Greenblatt 2015-12-31 Buy $8.28 - $12.44
($9.93)
$ 3.26-67%New holding19,424
BCRXGeorge Soros 2014-06-30 Sold Out -0.01%$7.37 - $12.52
($9.68)
$ 3.26-66%Sold Out0
BCRXGeorge Soros 2014-03-31 Buy 0.01%$7.6 - $12.83
($10.56)
$ 3.26-69%New holding59,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAKER BROS. ADVISORS LP10% Owner 2016-02-05Buy45,000$6.33-48.5view
BAKER BROS. ADVISORS LP10% Owner 2016-02-04Buy207,715$6.43-49.3view
BAKER BROS. ADVISORS LP10% Owner 2016-01-28Buy88,345$6.95-53.09view
BAKER BROS. ADVISORS LP10% Owner 2016-01-22Buy106,800$7.28-55.22view
BAKER BROS. ADVISORS LP10% Owner 2016-01-20Buy344,895$7.28-55.22view
STAAB THOMAS R IISenior Vice President and CFO 2015-12-21Sell3,052$10.86-69.98view
STAAB THOMAS R IISenior Vice President and CFO 2015-12-17Sell3,000$10.49-68.92view
STAAB THOMAS R IISenior Vice President and CFO 2015-07-20Sell3,500$16.5-80.24view
STAAB THOMAS R IISenior Vice President and CFO 2015-06-22Sell3,750$16-79.63view
Barnes Alane PVP, General Counsel & Corp Sec 2015-06-19Sell3,000$15-78.27view

Quarterly/Annual Reports about BCRX:

News about BCRX:

Articles On GuruFocus.com
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K/A) Jan 19 2011 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 2,500 Shares Aug 06 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares Jun 04 2010 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares May 05 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 38,553 Shares Apr 30 2010 
BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,249 Shares Apr 06 2010 

More From Other Websites
BioCryst to Announce First Quarter 2016 Financial Results May 5 Apr 21 2016
BioCryst to Announce First Quarter 2016 Financial Results May 5 Apr 21 2016
The best-run public companies in the Research Triangle area Apr 15 2016
7 Stocks Under $10 Making Big Moves Apr 15 2016
BioCryst to Present at Two Upcoming Investor Conferences Apr 07 2016
BioCryst to Present at Two Upcoming Investor Conferences Apr 07 2016
These 5 Biotech Stocks Under $10 Are About to Break Out Apr 01 2016
8 Major Biopharma Events Coming Later in 2016 and in 2017 Mar 29 2016
D. E. Shaw & Co Raises Exposure to Biocryst Pharmaceuticals Inc (BCRX) Mar 16 2016
The Biotech Bull Market Is Back Mar 09 2016
BioCryst to Present at Barclays Healthcare Conference Mar 09 2016
BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 08 2016
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 15.5% Mar 08 2016
Here's Why BioCryst Pharmaceuticals (BCRX) Stock is Spiking Today Mar 07 2016
BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 07 2016
BioCryst's Zika drug shows promise in mice Mar 07 2016
Study Results From Zika Virus Infected Mice Treated With BCX4430 to be Presented at WHO Conference Mar 07 2016
BIOCRYST PHARMACEUTICALS INC Financials Mar 04 2016
BIOCRYST PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Feb 26 2016
ETF’s with exposure to BioCryst Pharmaceuticals, Inc. : February 26, 2016 Feb 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)